Indian Drug Companies Urge Government to Stop Evergreening Tactics
These provisions were incorporated into an amendment passed last year, and it would be too early to assess their efficiency now, the industry claims.
The Indian government, which is drafting a third amendment to the act, has said the revisions would be "substantive" in nature, according to the Economic Times.
The Indian Pharmaceutical Alliance (IPA)...
To view the full article, register now.